Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma
Clinical trial NCT02892344 · COMPLETED
Trial details
- NCT number
- NCT02892344
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-16
- Primary completion
- 2018-11-05
- Enrollment
- 802
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.